Your Cart ( 1 Item )

• Topical Clofibrate Improves Symptoms in Patients With Atopic Dermatitis and Reduces Serum TARC Levels: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
  March 2014 | Volume 13 | Issue 3 | Original Article | 259 | Copyright © March 2014
  Mototsugu Fukaya MD^a and Hajime Kimata MD PHD^b
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs